Here, we studied the functions of RBM11 in ovarian cancer and found that RBM11 was overexpressed in ovarian cancer tissues and exerts oncogenic roles in ovarian cancer through activating Akt/mTOR signaling. The gene discussed is AKT1; the disease is ovarian carcinoma.